Building a blood cancer research database for future discoveries

The Indiana Myeloma Registry is a research database that collects blood samples and medical information from patients diagnosed with or suspected of having plasma cell disorders—conditions including MGUS, smoldering myeloma, multiple myeloma, plasmacytoma, and primary amyloidosis. The study does not test a specific medication or treatment; instead, it builds a resource that researchers can use to better understand these blood cancers and develop new therapies in the future.

Researchers need access to real patient samples and medical histories to understand how plasma cell disorders develop and progress, and to test new treatments. By creating this registry, scientists can study these diseases more effectively and work toward better care options for patients.